Regulatory product record
OPTICLEAR LIQ 0.44%
Product identity, ingredients and source provenance from the regulatory catalogue. Linked clinical evidence has a separate review status.
Product identity
- Brand name
- OPTICLEAR LIQ 0.44%
- DIN
- 00869333
- DPD drug code
- 11116
- Regulatory category
- APPROVED_VET_DRUG
- Market status
- MARKETED
- Route(s)
- OPHTHALMIC
- Pharmaceutical form(s)
- LIQUID
- Ingredients
- SODIUM CHLORIDE (0.44 %)
- Species (DPD record)
- CATS, DOGS
- Company
- TOMLYN PRODUCTS DIVISION OF VETOQUINOL USA INC. (DIN owner)
Source and provenance
- Source dataset
- health_canada_dpd_marketed
- Source snapshot date
- Not available in this source
- Source record key
- 11116
- Archive fingerprint (SHA-256)
- 85cc3ce208af3aa57018c3d14d83f90220c436baef7455384b6d48d9774e1c88
Linked clinical reference
Clinical entries are linked through the active molecule. Check their species, formulation, source and review status separately from this product record.
Clinical evidence
Dose regimens0
No dose regimens recorded for this species selection.
Adverse effects200
These are counts of spontaneously reported events, not proven adverse effects, causal relationships, or incidence rates.
Bars compare report counts within each species; they do not show incidence.
More reportsFewer reportsDog
- Vomiting47 reports
- Other abnormal test result NOS36 reports
- Death by euthanasia35 reports
- Death30 reports
- Lethargy (see also Central nervous system depression in 'Neurological')28 reports
- Lack of efficacy - NOS25 reports
- Diarrhoea24 reports
- Elevated alanine aminotransferase (ALT)24 reports
- Not eating24 reports
- Pain NOS23 reports
- Seizure NOS23 reports
- Anorexia22 reports
Cat
- Death20 reports
- Vomiting19 reports
- Behavioural disorder NOS18 reports
- Lethargy (see also Central nervous system depression in Neurological)18 reports
- Weight loss18 reports
- Anorexia15 reports
- Death by euthanasia15 reports
- Elevated creatinine15 reports
- Lethargy (see also Central nervous system depression in 'Neurological')15 reports
- Other abnormal test result NOS15 reports
- Dehydration14 reports
- Hyperglycaemia13 reports
Literature references15
References are linked to this drug. Species applicability is not recorded here, so the species filter does not narrow this list. Imported dates do not retain their original precision; confirm dates in the original citation.
- Modulation of sodium retention, diffusion, and saltiness perception via the interaction of Haematococcus pluvialis polysaccharides with oral mucins.
Study summary not available in the imported record. Open the original citation to review the study.
- Unraveling species-specific and stressor-associated halophyte responses to plant growth-promoting bacteria (PGPB) under extreme salinity and temperature conditions.
Study summary not available in the imported record. Open the original citation to review the study.
- Unraveling taste enhancement mechanism of yeast-inoculated reduced-salt fermented sausage: Proteolysis, taste compound formation, and receptor binding of potential salty/salty taste-enhancing peptides.
Study summary not available in the imported record. Open the original citation to review the study.
- Date palm by-products, fish waste, and Moringa oleifera as a cost-effective total mixed ration for fattening lambs: trade-offs between economic benefits and growth performance.
Study summary not available in the imported record. Open the original citation to review the study.
- Vitamin E supplementation moderates salt-induced oxidation status in beef.
Study summary not available in the imported record. Open the original citation to review the study.
Sources: PubMed, National Library of Medicine; openFDA, U.S. Food and Drug Administration.